← Back
Data updated: Mar 29, 2026
NOVUGEN PHARMA SDN
Cardiovascular
Generics
NOVUGEN PHARMA SDN is a generic drug manufacturer focused on Cardiovascular.
2025
Since
1
Drugs
-
Trials
14
Approved (2yr)
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
SACUBITRIL AND VALSARTAN 2026-01-20
SACUBITRIL AND VALSARTAN 2025-07-17
SACUBITRIL AND VALSARTAN 2025-07-16
SACUBITRIL AND VALSARTAN 2025-07-16
SACUBITRIL AND VALSARTAN 2025-01-13
SACUBITRIL AND VALSARTAN 2025-01-08
SACUBITRIL AND VALSARTAN 2024-10-16
SACUBITRIL AND VALSARTAN 2024-09-16
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2025-07-16
- Latest
- 2025-07-16
- Applications
- 1